Eirini Kelaiditi1, Sandrine Andrieu2, Christelle Cantet2, Bruno Vellas2, Matteo Cesari2. 1. Gérontopôle, Centre Hospitalier Universitaire de Toulouse, France. e.kelaiditi@gmail.com. 2. Gérontopôle, Centre Hospitalier Universitaire de Toulouse, France. Inserm UMR1027, Université de Toulouse III Paul Sabatier, France.
Abstract
BACKGROUND: The identification of an objective evaluation of frailty capable of predicting adverse outcomes in Alzheimer's disease is increasingly discussed. The purpose of this study was to investigate whether the Frailty Index (FI) predicts hospitalization, institutionalization, and mortality in Alzheimer's disease patients. METHODS: A prospective multicenter cohort study (follow-up = 2 years) that included 1,191 participants with Alzheimer's disease was carried out. The outcomes of interest were incident hospitalization, institutionalization, and mortality. The FI was calculated as the ratio of actual to thirty potential deficits, that is, deficits presented by the participant divided by 30. Severity of dementia was assessed using the Clinical Dementia Rating score. Cox proportional hazard models were performed. RESULTS: Mean age of the study sample was 76.2 (SD = 7.6) years. A quadratic relationship of the FI with age was reported at baseline (R (2) = .045, p < .001). The FI showed a statistically significant association with mortality (age- and gender-adjusted hazard ratio [HR] = 1.019, 95% confidence interval [CI] = 1.002-1.037, p = .031) and hospitalization (age- and gender-adjusted HR = 1.017, 95% CI = 1.006-1.029, p = .004) and a borderline significance with institutionalization. When the Clinical Dementia Rating score was simultaneously included in the age- and gender-adjusted models, the FI confirmed its predictive capacity for hospitalization (HR = 1.019, 95% CI = 1.006-1.032, p = .004), whereas the Clinical Dementia Rating score was the strongest predictor for mortality (HR = 1.922, 95% CI = 1.256-2.941, p = .003) and institutionalization (HR = 1.955, 95%CI = 1.427-2.679, p < .001). CONCLUSIONS: The FI is a robust predictor of adverse outcomes even after the stage of the underlying dementia is considered. Future work should evaluate the clinical implementation of the FI in the assessment of demented individuals in order to improve the personalization of care.
BACKGROUND: The identification of an objective evaluation of frailty capable of predicting adverse outcomes in Alzheimer's disease is increasingly discussed. The purpose of this study was to investigate whether the Frailty Index (FI) predicts hospitalization, institutionalization, and mortality in Alzheimer's diseasepatients. METHODS: A prospective multicenter cohort study (follow-up = 2 years) that included 1,191 participants with Alzheimer's disease was carried out. The outcomes of interest were incident hospitalization, institutionalization, and mortality. The FI was calculated as the ratio of actual to thirty potential deficits, that is, deficits presented by the participant divided by 30. Severity of dementia was assessed using the Clinical Dementia Rating score. Cox proportional hazard models were performed. RESULTS: Mean age of the study sample was 76.2 (SD = 7.6) years. A quadratic relationship of the FI with age was reported at baseline (R (2) = .045, p < .001). The FI showed a statistically significant association with mortality (age- and gender-adjusted hazard ratio [HR] = 1.019, 95% confidence interval [CI] = 1.002-1.037, p = .031) and hospitalization (age- and gender-adjusted HR = 1.017, 95% CI = 1.006-1.029, p = .004) and a borderline significance with institutionalization. When the Clinical Dementia Rating score was simultaneously included in the age- and gender-adjusted models, the FI confirmed its predictive capacity for hospitalization (HR = 1.019, 95% CI = 1.006-1.032, p = .004), whereas the Clinical Dementia Rating score was the strongest predictor for mortality (HR = 1.922, 95% CI = 1.256-2.941, p = .003) and institutionalization (HR = 1.955, 95%CI = 1.427-2.679, p < .001). CONCLUSIONS: The FI is a robust predictor of adverse outcomes even after the stage of the underlying dementia is considered. Future work should evaluate the clinical implementation of the FI in the assessment of demented individuals in order to improve the personalization of care.
Authors: Anna M Kucharska-Newton; Priya Palta; Sheila Burgard; Michael E Griswold; Jennifer L Lund; Benjamin D Capistrant; Stephen B Kritchevsky; Karen Bandeen-Roche; B Gwen Windham Journal: J Gerontol A Biol Sci Med Sci Date: 2017-03-01 Impact factor: 6.053
Authors: Melanie Dani; Lucy H Owen; Thomas A Jackson; Kenneth Rockwood; Elizabeth L Sampson; Daniel Davis Journal: J Gerontol A Biol Sci Med Sci Date: 2018-03-02 Impact factor: 6.053
Authors: Marco Canevelli; Ivan Arisi; Ilaria Bacigalupo; Andrea Arighi; Daniela Galimberti; Nicola Vanacore; Mara D'Onofrio; Matteo Cesari; Giuseppe Bruno Journal: Geroscience Date: 2020-11-19 Impact factor: 7.713
Authors: Sarah Dury; Eva Dierckx; Anne van der Vorst; Michaël Van der Elst; Bram Fret; Daan Duppen; Lieve Hoeyberghs; Ellen De Roeck; Deborah Lambotte; An-Sofie Smetcoren; Jos Schols; Gertrudis Kempen; G A Rixt Zijlstra; Jan De Lepeleire; Birgitte Schoenmakers; Dominique Verté; Nico De Witte; Tinie Kardol; Peter Paul De Deyn; Sebastiaan Engelborghs; Liesbeth De Donder Journal: BMC Public Health Date: 2018-01-30 Impact factor: 3.295
Authors: Alessandro Trebbastoni; Marco Canevelli; Fabrizia D'Antonio; Letizia Imbriano; Livia Podda; Lidia Rendace; Alessandra Campanelli; Valentina Celano; Giuseppe Bruno; Carlo de Lena Journal: Front Med (Lausanne) Date: 2017-10-23